About the series
Over 3 programmes, Professor Cliff Bailey and colleagues will be providing concise evidence-based guidance to contemporary medications and their application in daily care.
The aim: To assess the clinical evidence and opportunities offered by sodium-glucose co-transporter-2 (SGLT2) inhibitors in the management of type 2 diabetes and its cardio-renal complications.
Objectives:
- Understand the mode of action of SGLT2 inhibitors to inhibit the reabsorption of filtered glucose by the kidney
- Appreciate the metabolic effects of SGLT2 inhibitors on glycaemic control and body weight control in the management of type 2 diabetes
- Assess the effects of SGLT2 inhibitors on cardiac and vascular function
- Evaluate the role of SGLT2 inhibitors in the management of blood pressure, heart failure and atherosclerotic disease with and without type 2 diabetes
- Examine the emerging evidence for reno-protective effects of SGLT2 inhibitors
- Consider the potential opportunities for SGLT2 inhibitors in the management of diabetic kidney disease
Included in each programme:
- A one hour webinar including a live Q&A discussion
- Downloadable slides to print off and keep
- A downloadable factsheet summarising the guidance
- A case study based CPD learning module with certificate upon completion
The series will complete with 2 further update webinars later in the year, dates and times tbc.
![]() |
Programme 3 – SGLT2 inhibitors and the kidney
|
The series will complete with 2 further update webinars later in the year, dates and times tbc.
Your programme presenters
![]() |
Professor Cliff Bailey
Emeritus Professor of Clinical Science, Aston University, Birmingham |
![]() |
Professor Vinod Patel Professor, Diabetes and Clinical Skills, |
![]() |
Dr Martin Hadley-Brown
FRCGP, |
![]() |
Dr Pam Brown
GP, SA1 Medical Practice, |
Plus each programme has
- downloadable slides to print off and keep
- a downloadable factsheet of practical guidance
- an interactive CPD learning module with certificate upon completion
You can now watch Programme 1 & 2 on-demand. If you cannot attend any of the live broadcasts, the webinars will be available on-demand 24 hours after the event.
![]() |
Programme 1 – Understanding SGLT2 inhibition
|
![]() |
Programme 2 – SGLT2 inhibitors and the heart
|
Don’t forget to share this programme with a colleague click here
This webinar is supported by Boehringer Ingelheim through an unrestricted educational grant
The content, opinions and statements made in this webinar are those of the presenters and do not necessarily reflect the views of the supporters, editors or editorial board and no liability is accepted for the consequences of any misleading or inaccurate information.